Licensing arrangements - Purdue research foundation and other license agreements (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2024 |
Jan. 05, 2024 |
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
Product development and regulatory approval milestone payments | $ 6.0 | |
Commercial milestone payments | 7.5 | |
License Agreement with Purdue Research Foundation | ||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
Maximum amount payable | 3.8 | |
License Agreement with Purdue Research Foundation | Morphimmune Inc | ||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
License Agreement, upfront payment on execution | 0.2 | |
License Agreement, upfront payment on first and second anniversary | $ 0.1 | |
License agreement with Zentalis Pharmaceuticals, Inc | ||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
Maximum amount payable | $ 150.0 |